Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02951819
Title A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Janssen Scientific Affairs, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mobile Alabama United States Details
Phoenix Arizona United States Details
Sedona Arizona United States Details
Tucson Arizona United States Details
Fayetteville Arkansas United States Details
Greenbrae California United States Details
Denver Colorado United States Details
Niles Illinois United States Details
Indianapolis Indiana United States Details
Louisville Kentucky United States Details
Bethesda Maryland United States Details
Columbia Maryland United States Details
Grand Rapids Michigan United States Details
Omaha Nebraska United States Details
Camden New Jersey United States Details
Albany New York United States Details
East Setauket New York United States Details
Fresh Meadows New York United States Details
Cincinnati Ohio United States Details
Eugene Oregon United States Details
Greenville South Carolina United States Details
Austin Texas United States Details
Dallas Texas United States Details
San Antonio Texas United States Details
Tyler Texas United States Details
Seattle Washington United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field